Novel fluoroquinolones: design, synthesis, and in vivo activity in mice against Mycobacterium tuberculosis H37Rv
Authors:
- Anand V. ShindikarASAnand V. Shindikar
- C.L. ViswanathanCVC.L. Viswanathan
- 1 April 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (7) , 1803-1806
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Evaluation of Rifapentine in Long-Term Treatment Regimens for Tuberculosis in MiceAntimicrobial Agents and Chemotherapy, 1999
- Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?Antimicrobial Agents and Chemotherapy, 1997
- Structure−Activity Relationships of the Quinolone Antibacterials against Mycobacteria: Effect of Structural Changes at N-1 and C-7Journal of Medicinal Chemistry, 1996
- THE ENVELOPE OF MYCOBACTERIAAnnual Review of Biochemistry, 1995
- In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1995
- Nationwide Survey of Drug-Resistant Tuberculosis in the United StatesJAMA, 1994
- Pyridonecarboxylic acids as antibacterial agents. Part 14. Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potencyJournal of Medicinal Chemistry, 1990
- DNA Gyrase and the Supercoiling of DNAScience, 1980